112 related articles for article (PubMed ID: 6804131)
1. GnRH--test in menopause. Its possible use in identifying the subjects at risk for dysplastic endometrial pathology.
Marchesoni D; Gangemi M; Mozzanega B; Meneghetti G; Maggino T
Clin Exp Obstet Gynecol; 1981; 8(3):114-8. PubMed ID: 6804131
[TBL] [Abstract][Full Text] [Related]
2. Possibilities of clinical utilization of GnRH-test in menopause to identify the woman at risk for hormone-related pathology.
Marchesoni D; Mozzanega B; Maggino T
Eur J Gynaecol Oncol; 1983; 4(3):205-10. PubMed ID: 6444086
[TBL] [Abstract][Full Text] [Related]
3. Tamoxifen in the therapy of post-menopausal endometrial cancer: variations in some hormonal parameters.
Marchesoni D; Mozzanega B; Gangemi M; Enrichi M
Eur J Gynaecol Oncol; 1980 May; 1(2):116-21. PubMed ID: 6800794
[No Abstract] [Full Text] [Related]
4. Gonadotrophin response to releasing hormone in post-menopausal patients with ovarian tumours.
Mango D; Scirpa P; Liberati M; Manna P; Ricci S; Mancuso S
Maturitas; 1989 Jun; 11(2):129-36. PubMed ID: 2502703
[TBL] [Abstract][Full Text] [Related]
5. Hormone serum levels and hormone receptor contents of endometria in women with normal menstrual cycles and patients bearing endometrial carcinoma.
Spona J; Ulm R; Bieglmayer C; Husslein P
Gynecol Obstet Invest; 1979; 10(2-3):71-80. PubMed ID: 535775
[TBL] [Abstract][Full Text] [Related]
6. Effects of aging and gonadal failure on the hypothalamic-pituitary axis in women.
Santoro N; Banwell T; Tortoriello D; Lieman H; Adel T; Skurnick J
Am J Obstet Gynecol; 1998 Apr; 178(4):732-41. PubMed ID: 9579435
[TBL] [Abstract][Full Text] [Related]
7. Pituitary gonadotrophins and prolactin in patients with endometrial cancer, fibroids or ovarian tumours.
Ylikorkala O; Kauppila A; Rajala T
Br J Obstet Gynaecol; 1979 Nov; 86(11):901-4. PubMed ID: 116672
[TBL] [Abstract][Full Text] [Related]
8. Laboratory criteria for menopause in women using oral contraceptives.
Creinin MD
Fertil Steril; 1996 Jul; 66(1):101-4. PubMed ID: 8752618
[TBL] [Abstract][Full Text] [Related]
9. Pituitary self-priming actions of gonadotropin-releasing hormone. Kinetics of estradiol's potentiating effects on gonadotropin-releasing hormone-facilitated luteinizing hormone and follicle-stimulating hormone release in healthy postmenopausal women.
Veldhuis JD; Evans WS; Rogol AD; Kolp L; Thorner MO; Stumpf P
J Clin Invest; 1986 Jun; 77(6):1849-56. PubMed ID: 3086382
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of contraceptive steroid formulations containing two doses of estrogen on pituitary function.
Scott JZ; Kletzky OA; Brenner PF; Mishell DR
Fertil Steril; 1978 Aug; 30(2):141-5. PubMed ID: 98356
[TBL] [Abstract][Full Text] [Related]
11. Hormone levels in healthy post-menopausal women and in women with post-menopausal bleeding with or without endometrial carcinoma.
von Holst T; Klinga K; Runnebaum B
Maturitas; 1981 Dec; 3(3-4):315-20. PubMed ID: 6801439
[No Abstract] [Full Text] [Related]
12. Neuroendocrine regulation in depressed postmenopausal women and healthy subjects.
Amsterdam JD; Winokur A; Lucki I; Snyder P
Acta Psychiatr Scand; 1983 Jan; 67(1):43-9. PubMed ID: 6405581
[TBL] [Abstract][Full Text] [Related]
13. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
Reyes FI; Winter JS; Faiman C
Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
[TBL] [Abstract][Full Text] [Related]
14. Factors affecting pituitary gonadotropin function in users of oral contraceptive steroids.
Scott JA; Brenner PF; Kletzky OA; Mishell DR
Am J Obstet Gynecol; 1978 Apr; 130(7):817-21. PubMed ID: 345817
[TBL] [Abstract][Full Text] [Related]
15. [Hypothalamic -hypophyseal functional activity in amenorrhea. Comparison between GnRH stimulation response and the results of discriminative analysis of basal hormonal levels].
Venturoli S; Paradisi R; Gammi L; Jasonni VM; Flamigni C
Ann Ostet Ginecol Med Perinat; 1980; 101(5):319-31. PubMed ID: 6784639
[No Abstract] [Full Text] [Related]
16. Oestrogen production and metabolism in peri-menopausal women.
Reed MJ; Beranek PA; James VH
Maturitas; 1986 Mar; 8(1):29-34. PubMed ID: 3084922
[TBL] [Abstract][Full Text] [Related]
17. The effect of varying prolactin levels on pituitary luteinizing hormone and follicle-stimulating hormone response to gonadotropin-releasing hormone.
Spellacy WN; Cantor B; Kalra PS; Buhi WC; Birk SA
Am J Obstet Gynecol; 1978 Sep; 132(2):157-64. PubMed ID: 356613
[TBL] [Abstract][Full Text] [Related]
18. Correlation between climacteric symptoms and serum levels of estradiol, progesterone, follicle-stimulating hormone, and luteinizing hormone.
Abe T; Furuhashi N; Yamaya Y; Wada Y; Hoshiai A; Suzuki M
Am J Obstet Gynecol; 1977 Sep; 129(1):65-7. PubMed ID: 900171
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic studies on low dose estradiol 17 beta administered orally to postmenopausal women.
Sipinen S; Lähteenmäki P; Luukkainen T
Acta Obstet Gynecol Scand; 1980; 59(2):149-53. PubMed ID: 6773291
[TBL] [Abstract][Full Text] [Related]
20. Effects of short-term treatment with gonadotropin-releasing hormone (GnRH) or ethinyl estradiol on the pituitary responsiveness to GnRH.
Rozenman D; Ayalon D; Eckstein N; Eshel A; Lancet M
Gynecol Obstet Invest; 1983; 16(3):147-59. PubMed ID: 6413306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]